Tectonic Therapeutic | AVRO - Gross Profit On Sales


Tectonic Therapeutic reported $0 in Gross Profit on Sales for its fiscal quarter ending in March of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alnylam Pharmaceuticals USD 992.69M 167.68M Jun/2026
Celltrion KRW 39.29B 7.7B Mar/2026
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 19.61B 2.49B Jun/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Karyopharm Therapeutics USD 33.72M 1.13M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
MacroGenics USD 11.24M 19.87M Mar/2026
Medical Developments International AUD 7.35M 7.37M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organigram Holdings CAD 16.41M 6.91M Mar/2026
Pfizer USD -248M 11.29B Jun/2026
Pharma Mar EUR 44.87M 5.63M Jun/2026
Qiagen NV USD 340.39M 30.78M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sanofi EUR 8.71B 602M Jun/2026
Sarepta Therapeutics USD 251.15M 370.2M Jun/2026
Sartorius EUR 433.1M 18.6M Jun/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Takeda JPY 813.22B 124.39B Jun/2026
Tilray USD 57.47M 10.16M Jun/2025
Zealand Pharma A/S 34M 34.92M Mar/2026
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026